sever
acut
respiratori
syndrom
coronaviru
major
agent
endem
atyp
pneumonia
within
year
case
sar
least
death
record
worldwid
due
rapid
transmiss
viru
aerosol
high
mortal
rate
associ
genom
rapidli
sequenc
initi
show
close
relationship
group
although
surveil
measur
success
contain
spread
sar
human
virus
identifi
bat
natur
reservoir
also
abl
infect
cat
himalayan
palm
civet
warn
possibl
rout
interspeci
current
mainstream
treatment
strategi
sar
involv
antibiot
antivir
agent
immunomodulatori
therapi
drug
effect
improv
therapeut
option
develop
wider
varieti
drug
effect
method
combat
sar
import
singl
rna
genom
kb
length
encod
two
larg
replic
polyprotein
kda
kda
precursor
polyprotein
process
rang
structur
nonstructur
protein
viral
cystein
proteas
helicas
contain
three
major
domain
put
domain
mbd
hing
domain
ntpasehelicas
domain
helicas
absolut
necessari
subsequ
viral
replic
prolifer
thought
attract
target
new
drug
inde
viral
helicas
proven
drug
target
due
success
helicas
inhibitor
anim
model
herp
simplex
viru
hsv
treatment
hepat
previou
work
purifi
biochem
characteris
helicas
therebi
demonstr
enzym
belong
superfamili
enzym
unwind
rna
dna
duplex
polar
use
ntp
dntp
energi
sourc
enzymat
also
identifi
variou
inhibitor
compound
includ
compound
target
inhibitor
therapeut
impact
action
confin
small
surfac
area
target
thu
singl
amino
acid
chang
lead
significantli
reduc
efficaci
observ
evolut
strain
test
use
small
molecul
therefor
employ
vitro
select
strategi
name
systemat
evolut
ligand
exponenti
enrich
selex
isol
dna
sequenc
high
affin
approach
previous
report
inhibit
hiv
sivcpz
revers
transcriptas
use
overcom
resist
although
natur
phosphodiest
dna
rna
aptam
estim
lifetim
minut
blood
chemic
modifi
stabilis
studi
also
protect
aptam
cap
invert
thymidin
biotin
selex
use
selex
isol
dna
aptam
show
two
distinct
structur
circular
dichroism
gel
electrophoresi
stimul
atpas
activ
low
appar
k
valu
aptam
effici
specif
inhibit
activ
helicas
comparison
aptam
inhibit
helicas
activ
one
aptam
modifi
biotin
cap
evalu
term
inhibit
stabil
serum
helicas
overexpress
hexahistidin
tag
immobilis
protein
magnet
bead
solid
support
affin
chromatographi
screen
aptam
dna
librari
contain
random
core
sequenc
figur
method
present
homogen
popul
aptam
pool
coupl
select
process
facil
affin
chromatographi
bind
elut
step
decreas
chanc
select
contamin
increas
stringenc
select
excess
amount
polydeoxynucleotid
didc
ad
select
buffer
elimin
nonspecif
bound
aptam
aptam
bind
magnet
bead
protein
elimin
step
use
magnet
bead
alon
enrich
pool
specif
bound
helicas
check
seventh
round
select
littl
sequenc
enrich
observ
round
select
select
oligonucleotid
subsequ
amplifi
pcr
use
unmodifi
primer
allow
clone
aptam
pool
result
individu
aptam
clone
sequenc
shown
sequenc
guanosin
rich
figur
sequenc
like
fold
structur
figur
b
format
structur
aptam
predict
bioinformat
analysi
classifi
two
main
group
figur
sequenc
identifi
unlik
form
structur
group
align
group
aptam
similar
base
variat
differ
among
group
b
high
sequenc
homolog
observ
highli
conserv
sequenc
aptam
group
c
appar
orphan
sequenc
close
relat
group
contrast
aptam
aptam
less
sequenc
homolog
suggest
might
use
differ
mechan
bind
figur
b
howev
repeat
pattern
gg
n
xgg
n
deoxynucleotid
x
number
repeat
appear
pattern
like
fold
structur
five
aptam
includ
repres
group
characteris
secondari
structur
five
repres
aptam
experiment
analys
biophys
method
circular
dichroism
spectroscopi
gel
electrophoresi
employ
investig
whether
structur
form
put
aptam
guanin
repeat
sequenc
cd
spectra
show
posit
peak
nm
figur
spectrum
characterist
canon
howev
put
aptam
characterist
cd
spectra
differ
typic
cd
spectra
aptam
form
parallel
structur
typifi
posit
maximum
peak
near
nm
neg
peak
aptam
show
signatur
antiparallel
structur
characteris
posit
maximum
peak
near
nm
similar
previous
report
aptam
figur
schemat
depict
parallel
antiparallel
strand
orient
structur
shown
figur
c
respect
interestingli
specif
peak
wavelength
detect
aptam
incub
presenc
sodium
chlorid
buffer
figur
c
consist
previou
report
structur
stabl
presenc
potassium
ion
sodium
kcl
present
aptam
select
structur
relev
bind
scv
helicas
second
line
evid
topolog
quadruplex
aptam
investig
compar
mobil
polyacrylamid
gel
electrophoresi
oligonucleotid
ran
singl
band
denatur
polyacrylamid
gel
contain
urea
mobil
depend
denatur
size
figur
e
nativ
polyacrylamid
gel
figur
f
aptam
random
sequenc
migrat
singl
band
consist
lack
structur
cd
aptam
smaller
molecular
size
therefor
migrat
faster
aptam
put
monomer
cd
migrat
singl
band
gel
wherea
aptam
put
parallel
multimer
cd
migrat
two
band
gel
electrophoresi
data
show
multimer
band
consist
previou
cd
data
support
multimer
parallel
structur
assay
inhibitori
activ
aptam
helicas
activ
conduct
helicas
assay
base
fluoresc
reson
energi
transfer
fret
partial
label
duplex
dna
substrat
fluorophor
quencher
black
hole
quencher
previous
principl
behind
assay
shown
figur
helicas
abl
unwind
dna
rna
duplex
contain
dna
substrat
contain
dna
region
helicas
titrat
increas
concentr
select
aptam
data
collect
fit
logist
equat
figur
b
select
aptam
show
inhibit
helicas
differ
valu
aptam
observ
inhibit
duplex
substrat
unwind
valu
nm
respect
tabl
howev
aptam
appear
littl
inhibitori
activ
investig
whether
aptam
gener
helicas
inhibitor
aptam
subject
helicas
assay
use
escherichia
coli
dnab
helicas
also
unwind
direction
clone
express
purif
protein
report
found
aptam
inhibit
e
coli
dnab
assay
figur
c
wherea
concentr
aptam
inhibit
helicas
figur
b
concentr
aptam
also
show
signific
effect
dnab
nucleic
acid
unwind
activ
use
bovin
serum
albumin
bsa
instead
helicas
show
partial
duplex
dna
unwind
experi
result
suggest
select
aptam
act
gener
helicas
inhibitor
helicas
bind
ntp
exhibit
nucleic
acid
depend
intrins
ntpase
activ
necessari
energet
stabl
duplex
unwind
investig
effect
aptam
ntp
hydrolysi
use
previous
develop
colorimetr
assay
base
complex
triphenylmethan
tpm
dye
malachit
green
ammonium
interestingli
none
five
select
aptam
inhibit
atpas
activ
instead
stimul
atpas
activ
even
lower
concentr
random
nucleic
acid
sequenc
figur
might
suggest
aptam
bind
normal
nucleic
acid
bind
site
lock
enzym
conform
high
atpas
turnov
gener
featur
helicas
ntpase
activ
helicas
stimul
presenc
nucleic
set
appar
k
valu
obtain
stimul
atpas
assay
measur
strength
aptam
bind
helicas
atpas
activ
enzym
display
simpl
behaviour
presenc
differ
aptam
figur
appar
valu
bind
aptam
nm
respect
obtain
simpl
fit
atpas
data
figur
tabl
aptam
bound
tightli
aptam
helicas
nucleic
acid
bind
protein
random
sequenc
also
shown
bind
protein
less
tightli
appar
k
valu
nm
weaker
bind
affin
observ
aptam
natur
phosphodiest
dna
rna
ligand
suscept
degrad
nucleas
make
unsuit
therapeut
use
cap
one
commonli
use
approach
block
exonucleas
attack
therefor
stabil
aptam
modifi
thymidin
evalu
dmem
supplement
fb
figur
serum
condit
unmodifi
aptam
quickli
digest
nucleas
serum
figur
c
f
contrast
thymidin
aptam
strongli
resist
nucleas
attack
serum
case
thymidin
aptam
oligo
remain
intact
h
fb
respect
figur
thymidin
modif
higher
stabil
modif
modif
significantli
stabl
unmodifi
aptam
examin
whether
modif
aptam
either
thymidin
might
effect
inhibitori
activ
scv
helicas
figur
modifi
aptam
inhibit
nucleic
acid
unwind
activ
scv
helicas
slightli
lower
valu
unmodifi
one
tabl
wherea
modifi
random
sequenc
control
show
inhibit
specif
analysi
use
e
coli
dnab
reveal
modifi
aptam
show
gener
helicas
inhibit
suggest
modifi
aptam
retain
specif
figur
b
atpas
assay
modifi
aptam
stimul
atpas
activ
similar
fashion
unmodifi
aptam
figur
c
tabl
result
suggest
littl
impact
inhibitori
activ
aptam
shown
select
dna
aptam
bind
helicas
use
magnet
bead
immobilis
matrix
systemat
evolut
ligand
exponenti
enrich
selex
method
dna
aptam
structur
characteris
found
either
circular
dichroism
gel
electrophoresi
five
aptam
characteris
show
high
appar
bind
affin
helicas
stimul
atpas
activ
would
suggest
aptam
bind
nucleic
acid
bind
site
lock
high
atpas
turnov
conform
howev
aptam
unabl
inhibit
activ
suggest
structur
incap
lock
conform
previous
rna
aptam
select
hcv
helicas
domain
belong
superfamili
polar
show
consensu
hypothet
schemat
model
suggest
propos
aptam
act
decoy
competit
bind
nucleic
acid
bind
domain
inhibit
transloc
step
due
conserv
although
exact
model
mechan
scv
helicas
aptam
remain
extens
studi
aptam
might
perform
similar
way
helicas
first
bind
dna
aptam
transloc
direct
use
atp
energi
sourc
enzym
meet
aptam
enzym
lock
conform
explain
high
atpas
turnov
atpas
activ
hcv
helicas
previous
report
highli
stimul
oligomer
nucleic
acid
illustr
aptam
actual
stimul
rather
inhibit
atp
aptam
shown
potent
aptam
rel
high
bind
strength
inhibit
interestingli
aptam
isol
librari
reveal
sequenc
typic
structur
guanin
duplet
separ
two
three
deoxynucleotid
figur
structur
confirm
circular
dichroism
gel
electrophoresi
sequenc
select
previou
aptam
studi
exampl
dna
aptam
thrombin
rna
aptam
stabilis
potassium
ion
also
present
select
howev
first
demonstr
structur
specif
enzymat
inhibit
aptam
deriv
pool
similar
condit
furthermor
stabilis
one
aptam
thymidin
modif
show
aptam
still
potent
enough
inhibit
scv
helicas
particular
thymidin
modif
result
significantli
improv
half
life
serum
rna
aptam
helicas
recent
rna
aptam
identifi
helicas
inhibit
nm
famili
report
similarli
aptam
rna
aptam
also
inhibit
helicas
activ
inhibit
atpas
activ
suggest
pattern
behaviour
common
aptam
select
helicas
target
rna
aptam
provid
higher
structur
divers
help
inhibit
slightli
stronger
dna
aptam
target
howev
natur
rna
suscept
nucleas
attack
digest
less
minut
vivo
make
rna
incompat
mani
applic
without
stabilis
work
reveal
differenti
activ
helicas
aptam
isol
librari
pool
aptam
strongli
specif
inhibit
helicas
activ
aptam
howev
select
aptam
stimul
atpas
activ
strongli
strength
bind
valu
rang
compar
aptam
target
nucleic
acid
bind
aptam
show
best
potenc
characteris
modifi
cap
invert
thymidin
biotin
modif
made
aptam
resist
nucleas
attack
retain
aptam
potenc
studi
provid
new
mechanist
insight
structur
function
relationship
aptam
helicas
target
aptam
investig
new
approach
inhibit
replic
oligonucleotid
aptam
modifi
biotin
invert
thymidin
synthesis
molecular
informatrix
laboratori
ltd
mil
hong
kong
purifi
hplc
unless
otherwis
specifi
manufactur
use
synthesis
primer
aptam
appli
studi
aptam
tba
random
sequenc
design
control
respect
follow
tba
tgg
tgt
ggt
random
sequenc
ggc
cgt
tct
cag
tga
aca
aca
aaa
clone
express
purif
helicas
magnet
bead
prepar
helicas
domain
access
number
origin
denot
clone
express
purifi
previous
magnet
bead
prepar
first
equilibr
slurri
protein
bind
capac
magnet
bead
qiagen
hilden
germani
buffer
mm
ph
mm
kcl
mm
imidazol
triton
equilibr
bead
resuspend
buffer
purifi
helicas
mg
ad
mix
rotat
min
excess
helicas
supernat
wash
away
buffer
magnet
bead
wash
buffer
ml
concentr
helicas
buffer
store
vitro
select
vitro
select
perform
immedi
immobilis
helicas
prevent
protein
oxid
select
aptam
reli
magnet
separ
helicas
immobilis
magnet
bead
qiagen
start
point
select
process
random
degener
ssdna
oligonucleotid
librari
chemic
synthesis
purifi
hplc
librari
refer
selexapt
compos
random
nucleotid
flank
sequenc
suitabl
amplif
taa
tac
gac
tca
cta
tag
ggg
agc
tcg
gta
ccg
aat
ctt
tgc
aga
gag
gat
cct
primer
anneal
flank
degener
region
selexapt
use
select
clone
selexf
taa
tac
gac
tca
cta
tag
ggg
agc
tcg
gta
ccg
aat
selexr
gat
cct
ctc
tgc
aaa
gct
form
respect
hplc
purifi
iter
round
aptam
select
amplif
selex
process
modifi
previou
first
round
select
one
nanomol
selexapt
dilut
buffer
pcr
tube
heat
min
cool
librari
ad
buffer
ml
contain
bovin
serum
albumin
bsa
didc
helicas
pmol
materi
incub
rotat
min
tube
appli
magnet
separ
dynal
oslo
norway
remov
unbound
nucleic
acid
supernat
protein
bead
wash
buffer
ml
mix
gentl
invers
wash
step
helicas
bound
aptam
elut
magnet
bead
buffer
b
mm
ph
mm
kcl
mm
imidazol
triton
transfer
pcr
tube
amplif
pcr
reaction
volum
contain
pfx
polymeras
u
invitrogen
primer
selexf
biotinyl
selexr
dntp
mm
mm
enhanc
solut
amplif
condit
min
cycl
min
amplif
step
pcr
product
nacl
mix
streptavidin
magnet
bead
mg
dynal
min
room
temperatur
wash
buffer
ml
aptam
strand
separ
immobilis
complementari
strand
use
min
incub
fresh
naoh
mm
tube
appli
magnet
separ
ssdna
remov
dilut
buffer
next
round
select
perform
concentr
eluent
higher
last
wash
also
check
enrich
ssdna
bound
helicas
immobilis
magnet
bead
round
clone
sequenc
classif
round
materi
amplifi
pcr
selexf
selexr
primer
product
purifi
pcr
system
qiagen
clone
vector
invitrogen
transform
e
coli
compet
cell
coloni
pick
sampl
plasmid
purifi
qiaprep
spin
qiagen
plasmid
sequenc
use
revers
primer
termin
kit
presenc
structur
aptam
predict
sequenc
qgr
multipl
sequenc
align
perform
circular
dichroism
cd
spectroscopi
oligonucleotid
resuspend
mm
ph
buffer
contain
kcl
mm
nacl
mm
sampl
heat
min
follow
gradual
cool
room
temperatur
cd
spectra
collect
jasco
spectropolarimet
jasco
tokyo
japan
nm
use
scan
nm
respons
time
nm
bandwidth
quartz
cell
optic
path
length
mm
use
measur
gel
electrophoresi
oligonucleotid
sampl
label
fluorescein
isothiocyan
fitc
prepar
sodium
phosphat
buffer
mm
supplement
potassium
chlorid
mm
oligonucleotid
concentr
prior
perform
gel
assay
puriti
commerci
synthesis
oligom
check
run
polyacrylamid
gel
contain
urea
gel
assay
sampl
strand
concentr
heat
min
incub
h
nativ
polyacrylamid
gel
electrophoresi
perform
trisborateedta
tbe
buffer
supplement
kcl
mm
band
gel
visualis
uv
transillumin
assay
aptam
activ
concentr
qualiti
chemic
synthesis
aptam
accur
measur
urea
polyacrylamid
gel
electrophoresi
respect
appar
k
valu
obtain
determin
concentr
gave
stimul
atpas
activ
atpas
assay
perform
measur
amount
phosphat
releas
use
colorimetr
method
base
complex
malachit
green
ammonium
molybd
ammg
reagent
describ
helicas
assay
base
fret
fluorophor
black
hole
quencher
describ
previous
suitabl
two
oligom
synthesis
purifi
hplc
ttt
ttt
ttt
ttt
ttt
ttt
ttc
gag
cac
cgc
tgc
ggc
tgc
acc
releas
ggt
gca
gcc
gca
gcg
gtg
ctc
proligo
boulder
co
usa
two
oligom
anneal
mix
ratio
concentr
mm
ph
heat
cool
slowli
h
reaction
carri
ml
volum
nm
releas
oligom
nm
gca
gcc
gca
gcg
gtg
ctc
bsa
mg
scv
helicas
nm
mm
kcl
mm
kcl
mm
ph
min
reaction
initi
addit
atp
mm
chang
fluoresc
excit
nm
emiss
nm
min
use
monitor
extent
unwind
duplex
e
coli
dnab
fret
assay
carri
dnab
condit
control
determin
specif
use
e
coli
dnab
helicas
perform
describ
data
fit
use
origin
microc
softwar
northampton
usa
stabil
modifi
oligonucleotid
foetal
bovin
serum
fb
unmodifi
aptam
incub
fb
aliquot
reaction
remov
differ
time
interv
electrophoresi
reaction
stop
ad
formamid
gel
load
buffer
sampl
sampl
run
urea
page
tbe
buffer
visualis
stain
sybr
gold
nucleic
acid
stain
molecular
probe
eugen
usa
